Cargando…

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy

Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in MTC. To date, however, there are no published rev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grossrubatscher, Erika, Fanciulli, Giuseppe, Pes, Luca, Sesti, Franz, Dolci, Carlotta, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693147/ https://www.ncbi.nlm.nih.gov/pubmed/33138305 http://dx.doi.org/10.3390/jcm9113507

Ejemplares similares

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers
por: Giannetta, Elisa, et al.
Publicado: (2021)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020)

Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)

Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
por: Di Molfetta, Sergio, et al.
Publicado: (2022)

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
por: Beukhof, Carolien M., et al.
Publicado: (2019)

Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011)

Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Fanciulli, Giuseppe, et al.
Publicado: (2021)

Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs
por: Laffi, Alice, et al.
Publicado: (2023)

Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
por: Fanciulli, Giuseppe, et al.
Publicado: (2022)

Vitamin D and Cancer
por: Vuolo, Laura, et al.
Publicado: (2012)

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
por: Vitale, Giovanni, et al.
Publicado: (2020)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
por: Capodanno, Ylenia, et al.
Publicado: (2021)

Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
por: Vitale, Giovanni, et al.
Publicado: (2023)

Conus Medullaris Syndrome following Radionuclide Cisternography
por: Choi, Jay Chol
Publicado: (2014)

Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
por: Giannetta, Elisa, et al.
Publicado: (2021)

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review
por: Maghsoomi, Zohreh, et al.
Publicado: (2021)

Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family
por: Puliani, Giulia, et al.
Publicado: (2020)

Analysis of the lower incidence of medullary thyroid cancer in China
por: Huang, Min, et al.
Publicado: (2019)

Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
por: Albertelli, Manuela, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study
por: Faggiano, A, et al.
Publicado: (2012)

Genetic-Clinical Profile of Subjects with Apparently Sporadic Extra-Adrenal Paragangliomas
por: Ramundo, Valeria, et al.
Publicado: (2012)

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
por: Altieri, Barbara, et al.
Publicado: (2019)

Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
por: La Salvia, Anna, et al.
Publicado: (2021)

Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target
por: Modica, Roberta, et al.
Publicado: (2022)

A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors
por: Pozza, Carlotta, et al.
Publicado: (2020)

Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors
por: Barrea, Luigi, et al.
Publicado: (2021)

Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
por: Barrea, Luigi, et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues
por: Gallo, Marco, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
por: Czepczyński, Rafał, et al.
Publicado: (2014)

Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
por: Muscogiuri, Giovanna, et al.
Publicado: (2022)

Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1
por: Modica, Roberta, et al.
Publicado: (2023)

Association of Helicobacter pylori Infection with Autoimmune Thyroid Disease in the Female Sex
por: Dore, Maria Pina, et al.
Publicado: (2023)

SAT-566 Cofilin Is a Mediator of RET-Promoted Medullary Thyroid Carcinoma Cell Migration, Invasion and Proliferation
por: Peverelli, Erika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9cjahupgtighg0enrakqs3siuk